Chemoprevention of prostate cancer.
- Author:
Li-ping XIE
1
;
Jie QIN
Author Information
1. Department of Urology, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang 310003, China. xielp@zjuem.zju.edu.cn
- Publication Type:Journal Article
- MeSH:
Aged;
Aged, 80 and over;
Anticarcinogenic Agents;
therapeutic use;
Chemoprevention;
Humans;
Male;
Middle Aged;
Prostatic Neoplasms;
prevention & control
- From:
National Journal of Andrology
2005;11(4):243-246
- CountryChina
- Language:Chinese
-
Abstract:
In the western world, prostate cancer is a most common malignant neoplasm in human males. In recent years, its incidence has been rising dramatically in China. Prevention of this disease would have a positive impact on the disease-related cost, morbidity, and mortality for a large portion of the population. Cancer chemoprevention is defined as the use of natural, synthetic or biologic chemical agents to reverse, suppress, or prevent carcinogenic progression to invasive cancer. This article reviews the progress in chemoprevention of prostate cancer.
